A 20-year-old leveraged ETF investor in Queensland is set to benefit from strong Q2 tech earnings, according to Seeking Alpha analysis.
QLD: Q2 Tech Earnings Are Going To Be So… So Good For This 20-Year-Old Leveraged ETF
Browsing Category
Finance
71 posts
SpaceX lands investment-grade ratings as shares tumble
SpaceX secures its first investment-grade credit ratings from Moody’s, Fitch, and S&P, but its shares decline from recent highs amid market concerns.
SpaceX Bankers Prepare for Bond Sale of at Least $20 Billion
SpaceX bankers are preparing to hold investor calls next week for a bond offering of at least $20 billion, following its record IPO, according to sources.
Elon Musk’s SpaceX plots $20bn bond deal after record IPO
Elon Musk’s SpaceX is reportedly planning a $20 billion bond offering following its recent record-breaking IPO, signaling new funding strategies.
Japan megabanks to pay 2tn yen in dividends for 1st time
Japan’s three major banks will pay over 2 trillion yen in dividends this fiscal year, a historic high driven by rising interest rates after BOJ policy shift.
The Chainsmokers’ VC Firm Mantis Raising $100 Million Fund
The Chainsmokers’ venture capital firm Mantis is raising a $100 million fund to invest in startups, marking their entry into the investment space.
The unbundling of the budget app. Why a conversational finance surface absorbs what the personal-finance apps charge for, and what survives the absorption.
OpenAI’s launch of a conversational finance tool inside ChatGPT is transforming personal finance management, absorbing commodity layers and challenging standalone apps.
The bank account in the chat. How personal finance became an agentic on-ramp.
OpenAI introduces bank account integration in ChatGPT for Pro users, marking a shift toward agentic consumer finance interfaces and redefining fintech intermediation.
RF Industries, Ltd. (RFIL) Q2 2026 Earnings Call Transcript
RF Industries reports its Q2 2026 earnings, revealing financial results and outlook. Key figures and management insights analyzed.
Agios Pharmaceuticals, Inc. (AGIO) Discusses New Data and Strategic Expansion in Rare Hematology at EHA Investor Event – Slideshow
Agios Pharmaceuticals discusses new clinical data and strategic growth in rare hematology at EHA investor event, signaling potential advancements and market expansion.
